Renal and pulmonary effects of angiotensin converting enzyme inhibition in chronic hypoxic lung disease.
AUTOR(ES)
Oliver, R M
RESUMO
The effects of 28 days' treatment with captopril or with placebo on renal and pulmonary function were evaluated in nine patients with stable pulmonary heart disease. Captopril (25 mg twice daily) caused a 17% rise in effective renal plasma flow but no change in glomerular filtration rate, resulting in a fall in filtration fraction likely to favour natriuresis. Captopril did not alter FEV1, lung volumes, or arterial oxygen or carbon dioxide tension.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1020814Documentos Relacionados
- Effects of angiotensin converting enzyme inhibition on sodium excretion in patients with hypoxaemic chronic obstructive pulmonary disease.
- Doppler assessment of pulmonary haemodynamics in chronic hypoxic lung disease.
- Lung angiotensin converting enzyme activity in chronically hypoxic rats.
- Lung angiotensin converting enzyme activity in monocrotaline pulmonary hypertension.
- The angiotensin converting enzyme gene in cardiovascular disease.
